← FDA Drug Approvals (Drugs@FDA)
PACLITAXEL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2025-08-19
Drug application
- FDA Application #
ANDA217877- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PACLITAXEL
- Generic name
- PACLITAXEL
- Active ingredients
- PACLITAXEL
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- MYLAN
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2025-08-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown